International variation in management of screen-detected ductal carcinoma in situ of the breast
- 20 August 2014
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (15) , 2695-2704
Abstract
No abstract availableKeywords
Funding Information
- US National Cancer Institute
This publication has 32 references indexed in Scilit:
- Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2014
- Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern NetherlandsThe Breast, 2014
- Variation in detection of ductal carcinoma in situ during screening mammography: A survey within the International Cancer Screening NetworkEuropean Journal of Cancer, 2014
- Heterogeneity of ductal carcinoma in situ and its effects on managementThe Lancet Oncology, 2006
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI: Journal of the National Cancer Institute, 2006
- The natural history of ductal carcinoma in situ of the breast: a reviewBreast Cancer Research and Treatment, 2005
- Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989–2000European Journal Of Cancer Prevention, 2005
- Surgery and outcomes of ductal carcinoma in situ of the breast: a population-based study in AustraliaEuropean Journal of Cancer, 2004
- Detection of Ductal Carcinoma In Situ in Women Undergoing Screening MammographyJNCI: Journal of the National Cancer Institute, 2002
- Axillary lymph node dissection for intraductal breast carcinoma-is it indicated?Cancer, 1987